Our founders’ insights and achievements

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Inbiomotion and Source BioScience sign an exclusive agreement for MAF Test® in United Kingdom and Ireland

February 8, 2024

Criteria Bio Ventures leads €27 Mn round in AbolerIS Pharma to advance therapies against autoimmune diseases

September 18, 2023

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy

May 31, 2023

Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)

April 25, 2023

The Lancet Neurology publishes results from Minoryx Therapeutics Phase 2/3 ADVANCE clinical trial of leriglitazone in X-linked Adrenoleukodystrophy

January 20, 2023

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe

November 10, 2022

Positive results from AELIX’ HIV therapeutic vaccine clinical study AELIX-002 published in Nature Medicine

November 2, 2022

Minoryx‘s Marketing Authorization Application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked Adrenoleukodystrophy (X-ALD)

September 14, 2022

Minoryx raises €51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

May 31, 2022

Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M

November 24, 2021

Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest

October 9, 2020

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

October 8, 2020

Caixa Capital Risc is leading the largest operation in the biotech sector in Spain, with a €55 million financing round in Sanifit

June 26, 2019

Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia

June 4, 2019

Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia

February 28, 2019

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

October 18, 2018

NuMat Medtech secures a €530,000 round of investment

October 15, 2018

Minoryx Therapeutics raises €21.3M in Series B funding round

September 26, 2018

QIAGEN enters into agreement to acquire STAT-Dx, a Caixa Capital Risc portfolio company

February 1, 2018

MedLumics, a company owned by “la Caixa” and Ysios Capital, closes a financing round of 34.4 million euros

March 22, 2017

Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102

July 6, 2016

Stat Diagnostica announces 25 Million Euros in Series C Financing

April 11, 2016

”la Caixa” leads an investment round in Inbiomotion with the participation of Ysios Capital

March 9, 2016

Minoryx Therapeutics appoints Dr. Khalid Islam as chairman of the board of directors

January 27, 2016

Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine

January 11, 2016

PlantResponse Biotech raises 5.7 Million € in Series A funding

November 25, 2015

Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)

October 14, 2015

Sanifit raises €36.6M ($41.3M) in Series C financing round

September 8, 2015

”la Caixa” leads a 1.6 million Euro round in Minoryx

January 23, 2015

"la Caixa" leads 3.6 million euro financing round in Sanifit

November 17, 2014

nLife Therapeutics recibe 350.000 dólares americanos de la Fundación Michael J. Fox para la investigación de la enfermedad de Parkins

September 23, 2014

”la Caixa” and CRB Inverbío invest three million Euros in Nuubo, specialised in wearable technologies with medical applications

May 26, 2014

Laboratoris Sanifit begins the fight against calciphylaxis

April 14, 2014

Minoryx takes a step forward in the treatment of rare diseases

April 3, 2014

STAT-Diagnostica closes a 17 million euro financing round and brings in leading international investors

May 6, 2013

MedLumics Announces “BiopsyPen Project” with €3.6M EU in Funding

April 2, 2013

"la Caixa" and Inveready invest in Minoryx

April 2, 2013